Smokeless tobacco extracts activate complement in vitro: A potential pathogenic mechanism for initiating inflammation of the oral mucosa

Clinical Immunology and Immunopathology

Volumn 87, Issue 3, 1998, Pages 223-229

  Chang, Tunhan ^a   Chowdhry, Saurabh ^a   Budhu, Priya ^a   Kew, Richard R ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Complement; Inflammation; Periodontal disease; Smokeless tobacco

Indexed keywords

ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; HEMOLYSIS; HUMAN; MOUTH MUCOSA; MUCOSA INFLAMMATION; PATHOGENESIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; SMOKELESS TOBACCO; SMOKING;

EID: 0031751018     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4530     Document Type: Article

References (34)

1. Christen A. G. The impact of tobacco use and cessation on oral and dental diseases and conditions. Am. J. Med. 93:1992;25S-31S.
2. Kaugars G. E., Riley W. T., Brandt R. B., Burns J. C., Svirsky J. A. The prevalence of oral lesions in smokeless tobacco users and an evaluation of risk factors. Cancer. 70:1992;2579-2585.
3. Shirnamé-Moré L. Smokeless tobacco extracts mutate human cells. Carcinogenesis. 12:1991;927-930.
4. Lenz L. G., Ramp W. K., Sells-Gavin R. J., Pierce W. M. Jr. Inhibition of cell metabolism by a smokeless tobacco extract: tissue and species specificity. Proc. Soc. Exp. Biol. Med. 199:1992;211-217.
5. Jette A. M., Feldman H. A., Tennstedt S. L. Tobacco use: a modifiable risk factor for dental disease among the elderly. Am. J. Public Health. 83:1993;1271-1276.
6. Kew R. R., Ghebrehiwet B., Janoff A. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J. Clin. Invest. 75:1985;1000-1007.
7. Kew R. R., Ghebrehiwet B., Janoff A. The role of complement in cigarette smoke-induced chemotactic activity of lung fluids. Am. Rev. Respir. Dis. 133:1986;478-481.
8. Kew R. R., Ghebrehiwet B., Janoff A. The fifth component of complement (C5) is necessary for maximal pulmonary leukocytosis in mice chronically exposed to cigarette smoke. Clin. Immunol. Immunopathol. 43:1987;73-81.
9. Kew R. R., Ghebrehiwet B., Janoff A. Characterization of the third component of complement (C3) after activation by cigarette smoke. Clin. Immunol. Immunopathol. 44:1987;248-258.
10. Perricone R., DeCarolis C., DeSanctis G., Fontana L. Complement activation by cigarette smoke condensate and tobacco infusion. Arch. Environ. Health. 38:1983;176-179.
11. Robbins R. A., Nelson K. J., Gossman G. L., Koyama S., Rennard S. I. Complement activation by cigarette smoke. Am. J. Physiol. 260:1991;L254-L259.
12. Firpo A., Field F., Wellner D., Infante F., Becker C. G., Polley M. J. Chemical characterization of a low molecular weight component of cigarette smoke which activates the alternative pathway of complement. Complement. 2:1985;25.
13. Koethe S. M., Nelson K. E., Becker C. G. Activation of the classical pathway of complement by tobacco glycoprotein (TGP). J. Immunol. 155:1995;826-835.
14. Müller-Eberhard H. J. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:1988;321-347.
15. Kinoshita T. The biology of complement. Immunol. Today. 12:1991;291-295.
16. Schenkein H. A., Genco R. J. Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement and other plasma proteins. J. Periodontol. 48:1977;772-777.
17. Schenkein H. A., Genco R. J. Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, factor B and C4 in gingival fluid. J. Periodontol. 48:1977;778-784.
18. Shillitoe E. J., Lehner T. Immunoglobulins and complement in crevicular fluid, serum and saliva in man. Arch. Oral Biol. 17:1972;241-247.
19. Williams B. D., Challacombe S. J., Slaney J. M., Lachmann P. J., Lehner T. Immunoconglutinins and C3 in human saliva. Clin. Exp. Immunol. 19:1975;423-430.
20. Boackle R. J., Pruitt K. M., Silverman M. S., Glymph J. L. The effects of human saliva on the hemolytic activity of complement. J. Dental Res. 57:1978;103-110.
21. Chang N. S., Boackle R. J. Glycosaminoglycans enhance complement hemolytic efficiency: theoretical considerations for GAG-complement-saliva interactions. Mol. Immunol. 23:1986;887-893.
22. Okada H., Silverman M. S. Chemotactic activity in periodontal disease. J. Periodontal Res. 14:1979;20-25.
23. Okada H., Silverman M. S. Chemotactic activity in periodontal disease. II. Generation of complement derived chemotactic factors. J. Periodontal Res. 14:1979;147-152.
24. Niekrash C. E., Patters M. R. Simultaneous assessment of complement components C3, C4 and B and their cleavage products in human gingival fluid. I. Reliability of the method. J. Peridontal Res. 20:1985;260-267.
25. Niekrash C. E., Patters M. R. Simultaneous assessment of complement components C3, C4 and B and their cleavage products in human gingival fluid. II. Longitudinal changes during periodontal therapy. J. Peridontal Res. 20:1985;268-275.
26. Niekrash C. E., Patters M. R. Assessment of complement cleavage in gingival fluid in humans with and without periodontal disease. J. Peridontal Res. 21:1986;233-242.
27. Schenkein H. A., Berry C. R. Production of chemotactic factors for neutrophils following the interaction ofBacteroides gingivalis. J. Periodontal Res. 23:1988;308-312.
28. Wingrove J. A., DiScipio R. G., Chen Z., Potempa J., Travis J., Hugli T. E. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) fromPorphyromanas (Bacteroides) gingivalis. J. Biol. Chem. 267:1992;18902-18907.
29. Smokeless Tobacco Research Products.
30. Giannopoulou C., Demeurisse C., Cimasoni G. Elastase release from gingival crevicular and peripheral neutrophils in periodontitis and health. Arch. Oral Biol. 39:1994;741-745.
31. Van Dyke T. E., Lester M. A., Shapira L. The role of host response in periodontal disease progression: implications for future treatment strategies. J. Periodontol. 64:1993;792-806.
32. Robertson P. B., Wlash M., Greene J., Ernster V., Grady D., Hauck W. Peridontal effects associated with the use of smokeless tobacco. J. Periodontol. 61:1990;438-443.
33. Offenbacher S., Weathers D. R. Effects of smokeless tobacco on the periodontal and caries status of adolescent males. J. Oral Pathol. 14:1985;169-181.
34. Pabst M. J., Pabst K. M., Collier J. A., Coleman T. C., Lemons-Prince M. L., Godat M. S., Waring M. B., Babu J. P. Inhibition of neutrophil and monocyte functions by nicotine. J. Periodontol. 66:1995;1047-1055.